IHH subsidiary sues Japanese pharma company over Fortis Malar deal

The IHH unit is seeking to claim damages of JPY20b from the Japanese company.

Northern TK Venture, an indirect wholly owned subsidiary of IHH Healthcare, has filed a lawsuit against Japanese pharmaceutical company, Daiichi Sankyo for allegedly preventing them from proceeding with open offers to buy a stake at India’s Fortis Healthcare.

In a bourse filing, SGX-listed IHH Healthcare said its subsidiary filed a JPY20b claim against Daiichi Sankyo at the Tokyo District Court for causing losses to the former.

Under the lawsuit filed by NTK, Daiichi Sankyo will have to pay JPY20b with interest of 3% per annum.

“NTK is also seeking an injunction to prevent Daiichi Sankyo from making defamatory remarks against NTK concerning the open offers,” IHH Healthcare stated.

“The claims filed by NTK against Daiichi Sankyo are tort claims premised on the latter’s unlawful interference with NTK’s trade or business, conspiracy of Daiichi Sankyo and other persons, malicious falsehood and defamation under the applicable substantive laws,” the company added.

Follow the link for more news on

IHH Healthcare

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.

If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia